Literature DB >> 30905044

Performance of ultrasound for detection of transjugular intrahepatic portosystemic shunt dysfunction: a meta-analysis.

Wuttiporn Manatsathit1, Hrishikesh Samant2, Panadeekarn Panjawatanan3, Annie Braseth4, Jane Suh5, Mohammad Esmadi6, Noah Wiedel4, Thammasin Ingviya7.   

Abstract

PURPOSE: Although ultrasound has been widely used to evaluate transjugular intrahepatic portosystemic shunts (TIPS) patency, several studies have reported conflicting data regarding its performance. Therefore, we aimed to evaluate performance of ultrasound for detection of TIPS dysfunction by performing a meta-analysis.
METHODS: Literature search was performed for studies evaluating ultrasound for TIPS dysfunction, stenosis, and occlusion using PubMed, EMBASE, Scopus, and Cochrane Library through February 2019. Pooled sensitivity, specificity, log diagnostic odds ratio (LDOR), and area under curve (AUC) of summary receiver-operating characteristic were calculated. Subgroup analyses were performed according to ultrasonographic criteria and type of stent.
RESULTS: In total, 21 studies were evaluated. Pooled sensitivity, specificity, and LDOR of ultrasound for detection of TIPS dysfunction were 0.82 (0.67, 0.93), 0.58 (0.46, 0.70), and 1.77 (1.20, 2.35). Pooled sensitivity, specificity, and LDOR for TIPS stenosis were 0.80 (0.69, 0.90), 0.80 (0.69, 0.91), and 2.83 (1.88, 3.78). Pooled sensitivity, specificity, and LDOR for TIPS occlusion were 0.96 (0.92, 0.99), 1 (0.99, 1.00), and 6.28 (4.96, 7.60). AUCs of ultrasound for TIPS dysfunction, stenosis, and occlusion were 0.77, 0.86, and 0.95, respectively.
CONCLUSIONS: Although ultrasound had excellent performance for TIPS occlusion and acceptable performance for TIP stenosis, most studies utilized bare metal stent, and therefore, application to current practice is limited. Ultrasound for TIPS dysfunction in the setting of covered metal stent appeared to have acceptable sensitivity of 0.82, but limited specificity of 0.58 and low LDOR of 1.77. A new noninvasive tool is needed for detection of TIPS dysfunction in the era of covered metal stent.

Entities:  

Keywords:  Cirrhosis; Doppler ultrasonography; Portal hypertension; Stents; Transjugular intrahepatic portosystemic shunt

Year:  2019        PMID: 30905044     DOI: 10.1007/s00261-019-01981-w

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  4 in total

Review 1.  Transjugular intrahepatic portosystemic shunt (TIPS) complications: what diagnostic radiologists should know.

Authors:  Giuseppe Mamone; Mariapina Milazzo; Ambra Di Piazza; Settimo Caruso; Vincenzo Carollo; Giovanni Gentile; Francesca Crinò; Gianluca Marrone; Gianvincenzo Sparacia; Luigi Maruzzelli; Roberto Miraglia
Journal:  Abdom Radiol (NY)       Date:  2022-09-19

2.  Use of doppler ultrasound to predict need for transjugular intrahepatic portosystemic shunt revision.

Authors:  Nikki Duong; Marcus Healey; Kunal Patel; Brian J Strife; Richard K Sterling
Journal:  World J Hepatol       Date:  2022-06-27

3.  Spleen Stiffness Performance in the Noninvasive Assessment of Gastroesophageal Varices after Transjugular Intrahepatic Portosystemic Shunts.

Authors:  Huihui Zhou; Zhilin Zhang; Jun Zhang; Lin Sang; Lina Liu; Yong Lv; Xue Gong; Zhanxin Yin; Yuanyuan Sun; Guohong Han; Ming Yu
Journal:  Biomed Res Int       Date:  2021-04-17       Impact factor: 3.411

Review 4.  North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension.

Authors:  Justin R Boike; Bartley G Thornburg; Sumeet K Asrani; Michael B Fallon; Brett E Fortune; Manhal J Izzy; Elizabeth C Verna; Juan G Abraldes; Andrew S Allegretti; Jasmohan S Bajaj; Scott W Biggins; Michael D Darcy; Maryjane A Farr; Khashayar Farsad; Guadalupe Garcia-Tsao; Shelley A Hall; Caroline C Jadlowiec; Michael J Krowka; Jeanne Laberge; Edward W Lee; David C Mulligan; Mitra K Nadim; Patrick G Northup; Riad Salem; Joseph J Shatzel; Cathryn J Shaw; Douglas A Simonetto; Jonathan Susman; K Pallav Kolli; Lisa B VanWagner
Journal:  Clin Gastroenterol Hepatol       Date:  2021-07-15       Impact factor: 13.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.